0001437749-22-000316.txt : 20220104
0001437749-22-000316.hdr.sgml : 20220104
20220104173449
ACCESSION NUMBER: 0001437749-22-000316
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211231
FILED AS OF DATE: 20220104
DATE AS OF CHANGE: 20220104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bhalla Amit
CENTRAL INDEX KEY: 0001861065
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35076
FILM NUMBER: 22507732
MAIL ADDRESS:
STREET 1: 4995 BRADENTON AVE
STREET 2: SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000810509
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 311080091
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4995 BRADENTON AVENUE
STREET 2: SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
BUSINESS PHONE: 6147937500
MAIL ADDRESS:
STREET 1: 4995 BRADENTON AVENUE
STREET 2: SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
FORMER COMPANY:
FORMER CONFORMED NAME: NEOPROBE CORP
DATE OF NAME CHANGE: 19940714
4
1
rdgdoc.xml
FORM 4
X0306
4
2021-12-31
0000810509
NAVIDEA BIOPHARMACEUTICALS, INC.
NAVB
0001861065
Bhalla Amit
4995 BRADENTON AVE., SUITE 240
DUBLIN
OH
43017
1
Common Stock
2021-12-31
4
A
0
2500
0
A
45568
D
Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees.
Issuance deferred at the request of the Reporting Person.
/s/ Erika L. Eves for Amit Bhalla, by power of attorney
2022-01-04